Saturday 17 October 2026
Export RVTY’s income statement to Excel — free account
Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
152.64
2.07
−1.34%
Follow RVTY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
46.51 | 50.50 | 20.08 | 30.82 | 24.88 | 22.15 | 47.60 | 36.88 | 28.00 | 24.88 |
Piotroski F-Score |
6 | 6 | 5 | 5 | 4 | 6 | 6 | 7 | 3 | 7 |
P/S ratio |
3.95 | 4.97 | 5.01 | 5.38 | 6.10 | 6.01 | 3.73 | 3.13 | 3.60 | 2.74 |
Altman Z-Score |
2.49 | 2.88 | 2.43 | 2.62 | 2.83 | 3.67 | 3.07 | 2.88 | 2.47 | 3.19 |
Altman Z″-Score (non-manufacturers) |
3.86 | 4.33 | 3.70 | 3.45 | 3.01 | 3.58 | 3.18 | 3.09 | 2.60 | 4.04 |
P/FCF ratio |
22.35 | 25.53 | 2,808.13 | 30.22 | 17.70 | 19.33 | 38.07 | 33.95 | 32.42 | 17.07 |
Beneish M-Score |
(2.45) | (2.56) | (2.32) | (2.69) | (2.70) | (2.16) | (2.45) | (2.45) | (2.28) | (2.64) |
P/Operating CF |
61.97 | 78.64 | 70.04 | 127.95 | 69.60 | 33.19 | 50.00 | 54.48 | 63.39 | 39.01 |
Dividend Safety Score |
80 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.56 | 1.79 | 1.75 | 2.41 | 3.27 | 4.28 | 3.82 | 3.36 | 3.24 | 2.69 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
4.75 | 5.69 | 5.84 | 6.57 | 7.25 | 6.61 | 4.38 | 3.75 | 4.40 | 3.07 |
EV/EBITDA |
17.71 | 20.10 | 21.72 | 17.79 | 17.23 | 16.38 | 21.02 | 19.76 | 24.24 | 16.34 |
EV/Operating CF |
23.29 | 24.97 | 176.04 | 31.99 | 19.66 | 19.72 | 34.79 | 33.48 | 34.40 | 18.51 |
EV/FCF |
26.91 | 29.23 | 3,276.43 | 36.91 | 21.02 | 21.25 | 44.73 | 40.71 | 39.62 | 19.09 |
Quick Ratio |
1.25 | 2.75 | 1.54 | 0.69 | 1.08 | 0.94 | 1.20 | 1.03 | 0.79 | 1.30 |
Current Ratio |
1.68 | 3.60 | 2.07 | 2.13 | 2.01 | 1.36 | 1.80 | 1.60 | 1.26 | 1.97 |
Net Debt/EBITDA |
3.00 | 2.55 | 3.10 | 3.22 | 2.72 | 1.48 | 3.13 | 3.28 | 4.41 | 1.73 |
Debt/Assets |
26.46% | 25.42% | 28.75% | 31.10% | 33.23% | 25.01% | 31.72% | 31.65% | 32.93% | 24.47% |
Debt/Equity |
0.44 | 0.41 | 0.50 | 0.60 | 0.70 | 0.53 | 0.74 | 0.73 | 0.80 | 0.49 |
Asset Turnover |
0.23 | 0.21 | 0.20 | 0.23 | 0.33 | 0.37 | 0.46 | 0.46 | 0.44 | 0.50 |
Operating CF/Net income |
2.42 | 2.32 | 0.13 | 1.19 | 1.50 | 1.23 | 1.60 | 1.31 | 0.99 | 1.50 |
Capex/Depreciation |
(0.18) | (0.20) | (0.19) | (0.18) | (0.24) | (0.29) | (0.34) | (0.27) | (0.33) | (0.10) |
Interest Coverage |
4.04 | 11.33 | 2.56 | 8.17 | 22.93 | 12.91 | 2.90 | 4.89 | (268.01) | 5.83 |
| 3.23% | 3.48% | 9.09% | 7.84% | 17.34% | 22.23% | 8.43% | 9.35% | 12.57% | 10.99% | |
| 1.96% | 2.08% | 5.01% | 3.91% | 8.22% | 10.04% | 3.64% | 3.94% | 5.64% | 5.55% | |
ROIC |
2.33% | 2.24% | 1.85% | 4.10% | 6.83% | 10.18% | 4.82% | 4.69% | 4.29% | 6.48% |
Return on Tangible Assets |
17.38% | 12.41% | 33.64% | 25.56% | 55.07% | 76.22% | 24.47% | 30.44% | 53.49% | 32.00% |
Average Days of Receivables |
95.17 | 83.78 | 83.97 | 67.54 | 67.51 | 158.31 | 91.79 | 83.13 | 89.32 | 73.43 |
Research and Development Expense of Revenue |
7.56% | 7.14% | 7.87% | 6.69% | 5.23% | 5.50% | 6.57% | 6.98% | 6.18% | 5.87% |
Selling, General and Administrative Expense of Revenue |
34.73% | 36.08% | 37.18% | 30.97% | 25.48% | 26.90% | 28.27% | 29.23% | 27.74% | 27.91% |
Intangible Assets out of Total Assets |
0.74 | 0.73 | 0.70 | 0.70 | 0.70 | 0.60 | 0.67 | 0.69 | 0.71 | 0.62 |
Share Based Compensation of Revenue |
0.80% | 1.37% | 1.51% | 1.56% | 0.78% | 1.01% | 1.09% | 1.04% | 1.13% | 0.81% |
Graham Net Nets |
(0.24) | (0.17) | (0.20) | (0.19) | (0.23) | (0.12) | (0.22) | (0.25) | (0.29) | (0.16) |
Graham Number |
53.96 | 55.73 | 88.39 | 77.66 | 105.72 | 69.89 | 34.14 | 33.47 | 36.79 | 30.70 |
Earnings Yield |
2.15% | 1.98% | 4.98% | 3.25% | 4.02% | 4.52% | 2.10% | 2.71% | 3.57% | 4.02% |
Free Cash Flow Yield |
4.47% | 3.92% | 0.04% | 3.31% | 5.65% | 5.17% | 2.63% | 2.95% | 3.08% | 5.86% |
Revenue per Share |
24.51 | 22.44 | 22.06 | 26.25 | 32.95 | 23.88 | 26.02 | 25.13 | 20.54 | 19.32 |
Operating CF per Share |
5.00 | 5.12 | 0.73 | 5.39 | 12.14 | 8.00 | 3.28 | 2.81 | 2.63 | 3.20 |
Capex per Share |
(0.63) | (0.71) | (0.65) | (0.68) | (0.74) | (0.53) | (0.73) | (0.50) | (0.35) | (0.10) |
Free Cash Flow per Share |
4.37 | 4.41 | 0.08 | 4.71 | 11.40 | 7.47 | 2.55 | 2.31 | 2.28 | 3.10 |
Cash per Share |
7.89 | 9.48 | 12.86 | 3.60 | 5.19 | 3.61 | 1.73 | 1.48 | 1.84 | 3.28 |
Shareholders Equity per Share |
62.21 | 62.46 | 63.13 | 58.52 | 61.48 | 33.50 | 25.39 | 23.38 | 22.79 | 19.67 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
62.21 | 62.46 | 63.13 | 58.52 | 61.48 | 33.50 | 25.39 | 23.38 | 22.79 | 19.67 |
Free Cash Flow |
509.41 | 541.65 | 9.90 | 594.18 | 1,324.73 | 832.82 | 282.69 | 255.81 | 250.46 | 339.91 |
Working Capital |
908.50 | 1,696.51 | 1,550.63 | 1,744.08 | 1,227.04 | 586.73 | 611.55 | 463.00 | 249.05 | 586.58 |
Capital Expenditures |
(73.52) | (86.65) | (81.37) | (85.63) | (86.02) | (59.35) | (80.78) | (55.23) | (37.99) | (10.70) |
Net Current Asset Value |
(2,678.30) | (2,376.00) | (2,690.83) | (3,458.42) | (5,418.53) | (1,985.90) | (2,350.36) | (2,155.93) | (2,388.32) | (933.18) |
EV/EBIT |
38.07 | 45.24 | 53.46 | 29.28 | 22.04 | 20.28 | 34.93 | 32.15 | 33.57 | 22.03 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 |
Price to Operating Income |
31.62 | 39.51 | 45.82 | 23.97 | 18.56 | 18.45 | 29.73 | 26.81 | 27.47 | 19.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.86 | 0.90 | 0.86 | 0.99 | 0.72 | 0.56 | 0.75 | 0.64 | 0.38 | 0.70 |
Cash ROIC |
4.47% | 4.52% | 0.07% | 4.86% | 10.41% | 13.59% | 5.57% | 5.51% | 5.32% | 9.55% |
Accounts Receivable Turnover |
4.15 | 4.36 | 4.42 | 5.02 | 4.11 | 2.83 | 4.25 | 4.69 | 4.62 | 5.03 |
Accounts Payable Turnover |
7.32 | 6.55 | 5.08 | 4.42 | 4.27 | 3.31 | 6.51 | 6.49 | 6.07 | 7.13 |
Inventory Turnover |
3.46 | 3.06 | 2.91 | 3.18 | 2.96 | 2.14 | 4.28 | 4.17 | 3.95 | 4.35 |
Average Days of Payables |
52.41 | 50.21 | 61.53 | 75.33 | 85.06 | 128.05 | 57.87 | 56.12 | 68.51 | 55.70 |
Days of Inventory on Hand |
107.24 | 110.21 | 129.03 | 111.95 | 111.53 | 201.29 | 87.58 | 85.94 | 108.48 | 81.82 |
Average Receivables |
688.54 | 632.61 | 622.80 | 660.36 | 931.53 | 940.15 | 678.93 | 592.49 | 488.95 | 420.33 |
Average Payables |
176.46 | 185.79 | 238.47 | 298.82 | 326.07 | 281.59 | 228.40 | 221.52 | 195.06 | 154.51 |
Average Inventory |
373.54 | 397.82 | 416.76 | 415.68 | 470.23 | 435.75 | 347.64 | 345.01 | 299.26 | 253.17 |
Average Assets |
12,280.45 | 12,978.58 | 13,847.27 | 14,565.21 | 11,480.43 | 7,249.44 | 6,257.04 | 6,033.49 | 5,184.07 | 4,221.49 |
Average Common Equity |
7,458.62 | 7,769.81 | 7,627.81 | 7,262.06 | 5,438.37 | 3,274.66 | 2,699.39 | 2,544.07 | 2,328.38 | 2,132.01 |
Columns are period end dates